Eton Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 12.46
| ETON Stock | USD 12.07 0.03 0.25% |
Closest to current price Eton long CALL Option Payoff at Expiration
Eton |
Eton Pharmaceuticals Target Price Odds to finish over 12.46
The tendency of Eton Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 12.46 or more in 90 days |
| 12.07 | 90 days | 12.46 | about 5.0 |
Based on a normal probability distribution, the odds of Eton Pharmaceuticals to move over $ 12.46 or more in 90 days from now is about 5.0 (This Eton Pharmaceuticals probability density function shows the probability of Eton Stock to fall within a particular range of prices over 90 days) . Probability of Eton Pharmaceuticals price to stay between its current price of $ 12.07 and $ 12.46 at the end of the 90-day period is about 1.89 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.65 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Eton Pharmaceuticals will likely underperform. Moreover Eton Pharmaceuticals has an alpha of 1.3358, implying that it can generate a 1.34 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Eton Pharmaceuticals Price Density |
| Price |
Predictive Modules for Eton Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Eton Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Eton Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Eton Pharmaceuticals is not an exception. The market had few large corrections towards the Eton Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Eton Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Eton Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.34 | |
β | Beta against Dow Jones | 1.65 | |
σ | Overall volatility | 2.42 | |
Ir | Information ratio | 0.33 |
Eton Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Eton Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Eton Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Eton Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 31.64 M. Net Loss for the year was (936 K) with profit before overhead, payroll, taxes, and interest of 14.32 M. | |
| Latest headline from gurufocus.com: Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer |
Eton Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Eton Stock often depends not only on the future outlook of the current and potential Eton Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Eton Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 25.6 M | |
| Cash And Short Term Investments | 21.4 M |
Eton Pharmaceuticals Technical Analysis
Eton Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Eton Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Eton Pharmaceuticals. In general, you should focus on analyzing Eton Stock price patterns and their correlations with different microeconomic environments and drivers.
Eton Pharmaceuticals Predictive Forecast Models
Eton Pharmaceuticals' time-series forecasting models is one of many Eton Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Eton Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Eton Pharmaceuticals
Checking the ongoing alerts about Eton Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Eton Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Eton Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 31.64 M. Net Loss for the year was (936 K) with profit before overhead, payroll, taxes, and interest of 14.32 M. | |
| Latest headline from gurufocus.com: Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer |
Check out Eton Pharmaceuticals Backtesting, Eton Pharmaceuticals Valuation, Eton Pharmaceuticals Correlation, Eton Pharmaceuticals Hype Analysis, Eton Pharmaceuticals Volatility, Eton Pharmaceuticals History as well as Eton Pharmaceuticals Performance. To learn how to invest in Eton Stock, please use our How to Invest in Eton Pharmaceuticals guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eton Pharmaceuticals. If investors know Eton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eton Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.13) | Earnings Share (0.26) | Revenue Per Share 1.219 | Quarterly Revenue Growth (0.24) | Return On Assets (0.12) |
The market value of Eton Pharmaceuticals is measured differently than its book value, which is the value of Eton that is recorded on the company's balance sheet. Investors also form their own opinion of Eton Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eton Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eton Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eton Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eton Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eton Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eton Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.